Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (2) Gerhardt, Holger Prof. Dr. (1) Hübner, Norbert Prof. Dr. (1) Kammertöns, Thomas Dr. (4) Kopp, Joachim Dr. (2) Kunz, Severine Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (4) Patone, Giannino Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Poncette, Lucia (1) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (5) Willimsky, Gerald Dr. (2) (-) Beule, Dieter Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (14) Biologie maligner Lymphome (14) Epigenetische Regulation und Chromatinstruktur (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Integrative Vaskuläre Biologie (1) (-) Molekulare Immunologie und Gentherapie (14) Psychoneuroimmunologie (1) Systembiologie von Gen-regulatorischen Elementen (1) Translational Bioinformatics (4) Tumorgenetik und zelluläre Stressantworten (1) Zelluläre Neurowissenschaften (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) (-) 2011 (5) 2012 (6) 2013 (11) 2014 (3) (-) 2015 (3) 2016 (4) (-) 2017 (6) 2018 (4) 2019 (6) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 14 Ergebnisse: Active Filter: Beule, Dieter Dr.Blankenstein, Thomas Prof. Dr.Molekulare Immunologie und Gentherapie 201120152017 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 06. November 2017 / J Exp Med Human TCR-MHC coevolution after divergence from mice includes increased nontemplate-encoded CDR3 diversity X. Chen L. Poncette T. Blankenstein 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein 15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 01. November 2011 / Eur J Immunol Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors J. Charo C. Perez C. Buschow A. Jukica M. Czeh T. Blankenstein 15. September 2017 / Canc Res CTLA4 promotes Tyk2-STAT3 dependent B-cell oncogenecity A. Herrmann C. Lahtz T. Nagao J.Y. Song W.C. Chan H. Lee C. Yue T. Look R. Muelfarth W. Li K. Jenkins J. Williams L.E. Budde S.J. Forman L.W. Kwak T. Blankenstein H. Yu 04. Mai 2017 / Nature Tumour ischaemia by interferon-γ resembles physiological blood vessel regression T. Kammertoens C. Friese A. Arina C. Idel D. Briesemeister M. Rothe A. Ivanov A. Szymborska G. Patone S. Kunz D. Sommermeyer B. Engels M. Leisegang A. Textor H.J. Fehling M. Fruttiger M. Lohoff A. Herrmann H. Yu R. Weichselbaum W. Uckert N. Hübner H. Gerhardt D. Beule H. Schreiber T. Blankenstein 15. Oktober 2017 / Clin Cancer Res T cell receptors for clinical therapy: in vitro assessment of toxicity risk A. Kunert M. Obenaus C.H.J. Lamers T. Blankenstein R. Debets 15. Dezember 2017 / Int J Cancer The immune system prevents recurrence of transplanted but not autochthonous antigenic tumors after oncogene inactivation therapy K. Anders O. Kershaw L. Larue A.D. Gruber T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
06. November 2017 / J Exp Med Human TCR-MHC coevolution after divergence from mice includes increased nontemplate-encoded CDR3 diversity X. Chen L. Poncette T. Blankenstein
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein
15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
01. November 2011 / Eur J Immunol Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors J. Charo C. Perez C. Buschow A. Jukica M. Czeh T. Blankenstein
15. September 2017 / Canc Res CTLA4 promotes Tyk2-STAT3 dependent B-cell oncogenecity A. Herrmann C. Lahtz T. Nagao J.Y. Song W.C. Chan H. Lee C. Yue T. Look R. Muelfarth W. Li K. Jenkins J. Williams L.E. Budde S.J. Forman L.W. Kwak T. Blankenstein H. Yu
04. Mai 2017 / Nature Tumour ischaemia by interferon-γ resembles physiological blood vessel regression T. Kammertoens C. Friese A. Arina C. Idel D. Briesemeister M. Rothe A. Ivanov A. Szymborska G. Patone S. Kunz D. Sommermeyer B. Engels M. Leisegang A. Textor H.J. Fehling M. Fruttiger M. Lohoff A. Herrmann H. Yu R. Weichselbaum W. Uckert N. Hübner H. Gerhardt D. Beule H. Schreiber T. Blankenstein
15. Oktober 2017 / Clin Cancer Res T cell receptors for clinical therapy: in vitro assessment of toxicity risk A. Kunert M. Obenaus C.H.J. Lamers T. Blankenstein R. Debets
15. Dezember 2017 / Int J Cancer The immune system prevents recurrence of transplanted but not autochthonous antigenic tumors after oncogene inactivation therapy K. Anders O. Kershaw L. Larue A.D. Gruber T. Blankenstein